Evaluating the Success of Habitual Multifocal Wearers When Refit With a New Lens Design

April 25, 2022 updated by: CooperVision, Inc.
The objective of the study was to adapt existing multifocal soft lens wearers to a CONTROL lens for 2 weeks and then evaluate the success of switching them to the TEST lens, with a review after 2 weeks.

Study Overview

Status

Completed

Conditions

Detailed Description

This was a prospective, crossover, bilateral daily wear, and subject masked dispensing study. The habitual contact lenses were not optimized. There was no randomization of the study lenses, participants wore the control lenses for the first wear period and the test for the second wear period. Participants wore each study lens for 3-7 days and then attend a prescription optimization visit. After this optimization visit, they wore each study lens for a 2-week period. During the 2-week wear period, participants recorded their subjective lens-wear experience remotely.

Study Type

Interventional

Enrollment (Actual)

63

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Florida
      • Ocoee, Florida, United States, 34761
        • Coan Eyecare
    • Kansas
      • Pittsburg, Kansas, United States, 66762
        • Kannarr Eye Care
    • New York
      • Vestal, New York, United States, 13850
        • Sacco Eye Group PLLC
    • Ohio
      • Granville, Ohio, United States, 43023
        • ProCare Vision Center
    • Pennsylvania
      • College, Pennsylvania, United States, 16801
        • Nittany Eye Associates

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

42 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Is at least 42 years of age and has full legal capacity to volunteer;
  2. Has read and signed an information consent letter;
  3. Self reports having a full eye examination in the previous two years;
  4. Anticipates being able to wear the study lenses for at least 8 hours a day, 5 days a week;
  5. Is willing and able to follow instructions and maintain the appointment schedule;
  6. Habitually wears multifocal soft contact lenses, for the past 3 months minimum;
  7. Has refractive astigmatism no higher than -0.75DC;
  8. Is presbyopic and requires a reading addition of at least +0.75D and no more than

    +2.50D;

  9. Can be fit and achieve binocular distance vision of at least 20/30 Snellen (or +0.20 logMAR) which participants also deem to be 'acceptable', with the available study lens parameters (powers +4.00 to -6.00DS)

Exclusion Criteria:

  1. Is participating in any concurrent clinical or research study;
  2. Has any known active* ocular disease and/or infection that contraindicates contact lens wear;
  3. Has a systemic condition that in the opinion of the investigator may affect a study outcome variable;
  4. Is using any systemic or topical medications that in the opinion of the investigator may affect contact lens wear or a study outcome variable;
  5. Has known sensitivity to the diagnostic sodium fluorescein used in the study;
  6. Self-reports as pregnant, lactating or planning a pregnancy at the time of enrolment;
  7. Has undergone refractive error surgery or intraocular surgery.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Control Lens
All subjects will wear control lenses for two weeks and then will wear Test lenses for two weeks.
Control Multifocal lenses
Test Multifocal lenses
Experimental: Test Lens
After wearing control lenses for two weeks, all subjects will wear test lenses for two weeks.
Control Multifocal lenses
Test Multifocal lenses

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Comfort on Insertion
Time Frame: Day 1 after Lens Dispense Visit
Subjective ratings of comfort on insertion using a 0-10 scale, in 0.5 steps (0=- painful, 10- Can't feel the lenses).
Day 1 after Lens Dispense Visit

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Lyndon Jones, University of Waterloo

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 21, 2021

Primary Completion (Actual)

December 1, 2021

Study Completion (Actual)

January 14, 2022

Study Registration Dates

First Submitted

June 28, 2021

First Submitted That Met QC Criteria

June 28, 2021

First Posted (Actual)

July 7, 2021

Study Record Updates

Last Update Posted (Actual)

April 27, 2022

Last Update Submitted That Met QC Criteria

April 25, 2022

Last Verified

April 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EX-MKTG-119

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Presbyopia

Clinical Trials on Control lenses

Subscribe